About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Tumor Vaccines for Solid Tumors | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT06102837

Tumor Vaccines for Solid Tumors

Glioma is the most common primary malignant intracranial tumor, characterized by limited clinical treatment options and extremely poor prognosis. There is an urgent need for the development of new tec...

Lead sponsor: Huashan Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Huashan Hospital

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•The patients with glioma patients/non-tumor patients (hemorrhagic stroke, ischemic stroke, and traumatic brain injury) in the Department of Neurosurgery of Huashan Hospital Affiliated to Fudan University who meet the following three conditions can be enrolled:
•1. They were no age limit, male and female;
•2. The pathological results of frozen section during operation were gliomas or non-tumor;
•3. Tissue (6 mm \* 6 mm) can be used for cell sorting on the basis of not affecting clinical routine diagnosis;
•4. Sign informed consent.

Exclusion Criteria

•Patients who meet any of the following criteria will not be included in this study:
•1. Participants in other clinical trials;
•2. Pregnant women.

Related studies

RECRUITINGPhase 1

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

NCT06132828 · Solid Tumor

RECRUITINGPhase 2

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

NCT04570423 · Solid Tumors, Lymphoma

RECRUITINGPhase 1/2

GT201 Injection For The Treatment Of Advanced Solid Tumors

NCT06144671 · Solid Tumor, Adult

RECRUITINGPhase 1/2

A Study of Mirdametinib in People With Central Nervous System Tumors

NCT07539441 · Central Nervous System Tumors, Glioma

RECRUITINGPhase 2

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

NCT03206060 · Pheochromocytoma, Paraganglioma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 26, 2023Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment340

Start dateOct 2023

Last updatedOct 26, 2023

Condition

Glioma Solid Tumor

Locations shown

Huashan Hospital, Fudan University

Shanghai, Shanghai Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 26, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions